Company Overview and News

55
Universal’s ‘Jurassic World: Fallen Kingdom’ poised to win big chunk of U.S. box office - MarketWatch

14h marketwatch
Analysts estimate an opening weekend gross of $130 million to $140 million—a substantial amount, though not as large as its predecessor’s
CCV.CL CCV CMCSA CCZ CMCSK

409
Dow 30 Stock Roundup: Disney Ups Bid for Fox Assets, Boeing Wins $6.6B FedEx Contract

22h zacks
The Dow traversed a difficult week, declining over every single trading session. These losses were primarily attributable to an escalation in the trade conflict between the United States and China. President Trump expressed his intention to impose additional tariffs on Chinese goods. Toward the end of the week, tech stocks managed to recover from trade tensions. But industrials continued to be weighed down by the looming trade war.
IBM FOX GEC GE CAT CCV CMCSA WBA FDX CCZ GOOGL CCV.CL BOE AAPL GNE MSFT INTC BA FOXA CMCSK DIS

69
Disney Promises to Double Fox Asset Sales to Win Antitrust Approval - Bloomberg

2018-06-21 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
CCV.CL CCV CMCSA CCZ CMCSK DIS

80
Disney willing to divest more Fox assets for deal clearance

2018-06-21 channelnewsasia
REUTERS: Walt Disney Co said on Thursday it was willing to divest Twenty-First Century Fox Inc assets that generated up to US$1 billion in earnings before interest, tax, depreciation and amortization (EBITDA) to get a regulatory nod for the deal.
FOX CCV.CL CCV CMCSA NFLX CCZ CMCSK FOXA DIS

74
Disney willing to divest more Fox assets for deal clearance

2018-06-21 reuters
(Reuters) - Walt Disney Co (DIS.N) said on Thursday it was willing to divest Twenty-First Century Fox Inc (FOXA.O) assets that generated up to $1 billion in earnings before interest, tax, depreciation and amortization to get a regulatory nod for the deal.
FOX CCV.CL CCV CMCSA CCZ CMCSK FOXA DIS

55
Standing Between Comcast and Fox: Media Titans’ Rocky Relationship - WSJ

2018-06-21 wsj
At one point last fall, Comcast Corp. Chief Executive Brian Roberts and other top executives at the cable giant thought they were near the deal of a lifetime to buy Rupert Murdoch’s entertainment assets.
CCV.CL CCV CMCSA CCZ CMCSK

295
Stock Market News For Jun 21, 2018

2018-06-21 zacks
The Nasdaq and S&P 500 closed higher on Wednesday, while the Dow continued its decline for the seventh consecutive day. The Nasdaq closed at a record high, led by a rally in large-cap tech stocks after Walt Disney raised its bid for Twenty-First Century Fox to $71.3 billion surpassing Comcast Corporation’s bid of $65 billion. However, growing fears of a U.S.-China trade war continued to take its toll on the Dow and S&P 500.
FB HES CCV TWX MS.PRE MS.PRF NFLX CCZ MS.PRG MS.PRA HES.PRA AAPL MS CMCSK VLKAY DIS FOX CMCSA TWC NDAQ MS.PRI GOOGL CCV.CL MS.PRK FOXA

74
Investor Odey says Sky could be worth as much as 50 billion pounds

2018-06-21 channelnewsasia
LONDON: Top-20 Sky investor Crispin Odey said he expects the bidding war for the media company to carry on over the summer and that the European broadcaster could be worth as much as 50 billion pounds (US$65.5 billion).
FOX CCV.CL CCV CMCSA CCZ CMCSK FOXA DIS

74
Investor Odey says Sky could be worth as much as 50 billion pounds

2018-06-21 reuters
LONDON (Reuters) - Top-20 Sky (SKYB.L) investor Crispin Odey said he expects the bidding war for the media company to carry on over the summer and that the European broadcaster could be worth as much as 50 billion pounds ($65.5 billion).
FOX CCV.CL CCV CMCSA CCZ CMCSK FOXA DIS

171
Is Disney's Counter Bid Paving the Way for Media Consolidation?

2018-06-21 zacks
On Jun 20, The Walt Disney Company (DIS - Free Report) in a not-so-surprising move sweetened its bid to acquire Twenty-First Century Fox, Inc.’s (FOXA - Free Report) assets, surpassing Comcast Corporation’s (CMCSA - Free Report) all-cash offer of $65 billion made last week.
FOX AMZN CCV.CL CCV CMCSA TWX NFLX CCZ TWC FOXA CMCSK DIS

74
Dollar scales 11-month peak, oil slides ahead of OPEC

2018-06-21 theedgemarkets
LONDON/SYDNEY (June 21): Simmering trade and political tensions weighed on European and world shares on Thursday, while oil prices were under pressure ahead of an OPEC meeting that could boost the global supply of crude.
FOX CCV.CL CCV CMCSA CCZ CMCSK FOXA DIS

74
Dollar scales 11-month peak, oil slides ahead of OPEC meet

2018-06-21 thehindubusinessline
The dollar powered to an 11-month high in the currency market, maintaining pressure on inflation and on countries and firms that have gorged themselves on dollar-denominated debt in recent years.
FOX CCV.CL CCV CMCSA JINDALSAW CCZ 500378 FOXA CMCSK DIS

74
Dollar scales 11-month peak, oil slides ahead of OPEC

2018-06-21 channelnewsasia
Simmering trade and political tensions weighed on European and world shares on Thursday, while oil prices were under pressure ahead of an OPEC meeting that could boost the global supply of crude.
FOX CCV.CL CCV CMCSA CCZ CMCSK FOXA DIS

117
6 Most Important Things In Business Today

2018-06-21 247wallst
21st Century Fox (NASDAQ: FOX) said it would sell a number of its assets to Walt Disney (NYSE: DIS). According to The Wall Street Journal:
FOX AMC CCV.CL CCV AOBC CMCSA NFLX CCZ CMCSK DIS

81
PRESS DIGEST -Wall Street Journal - June 21

2018-06-21 reuters
June 21 (Reuters) - The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy.
CCV.CL CCV CMCSA CG CCZ CMCSK DIS

Related Articles

CASC: Cascadian Therapeutics Analysis and Research Report

2018-06-22 - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

2018-06-22 - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

CUSIP: 20030N606